A2 Biotherapeutics has raised $80 million to run three experimental CAR-T programs for solid tumor cancers. The ...
Healthcare-focused SaaS firm Innovaccer Inc. has secured $275 million in funding from investors including B Capital Group and ...
The last round in 2021 valued the healthcare technology firm at $3.2 billion, more than doubling its valuation from $1.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback